Direct and indirect effects of a combination of adipose-derived stem cells and platelet-rich plasma on bone regeneration

Tissue Engineering - Part A

Volumn 21, Issue 5-6, 2015, Pages 895-905

  Tajima, Satoshi ^a,b   Tobita, Morikuni ^a   Orbay, Hakan ^c   Hyakusoku, Hiko ^d   Mizuno, Hiroshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JPN Self Defense Forces Hospital Yokosuka   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENGINEERING; COMPUTERIZED TOMOGRAPHY; DEFECTS; MOBILE SECURITY; PLASMA (HUMAN); PLATELETS; RATS; REPAIR; STEM CELLS;

ADIPOSE DERIVED STEM CELLS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-1; MICROCOMPUTED TOMOGRAPHY; PLATELET RICH PLASMA; TRANSFORMING GROWTH FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BONE;

OSTEOCALCIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR AB; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; GREEN FLUORESCENT PROTEIN; SIGNAL PEPTIDE;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE; FRACTURE HEALING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; PLATELET-RICH PLASMA CELL; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SKULL DEFECT; STEM CELL TRANSPLANTATION; THROMBOCYTE; THROMBOCYTE COUNT; TISSUE ENGINEERING; TISSUE SCAFFOLD; ADIPOSE TISSUE; ANIMAL; BONE; CELL CULTURE; CYTOLOGY; FISCHER 344 RAT; METABOLISM; NUDE RAT; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; STAINING; STEM CELL; THROMBOCYTE RICH PLASMA; TRANSGENIC MOUSE; ULTRASTRUCTURE;

BOVINAE; RATTUS;

ADIPOSE TISSUE; ANIMALS; BONE AND BONES; BONE REGENERATION; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE, TRANSGENIC; OSTEOCALCIN; OSTEOPONTIN; PLATELET COUNT; PLATELET-RICH PLASMA; RATS, INBRED F344; RATS, NUDE; STAINING AND LABELING; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84924390308     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0336     Document Type: Article

References (58)

1. Weiner, S., Traub, W., and Wagner, H.D. Lamellar bone: structure-function relations. J Struct Biol 126, 241, 1999.
2. Nguyen, L.H., Annabi, N., Nikkhah, M., Bae, H., Binan, L., Park, S., Kang, Y., Yang, Y., and Khademhosseini, A. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev 18, 363, 2012.
3. Oikarinen, J., and Korhonen, L.K. The bone inductive capacity of various bone transplanting materials used for treatment of experimental bone defects. Clin Orthop Related Res 140, 208, 1979.
4. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: state of the art and future trends. Macromol Biosci 4, 743, 2004.
5. Goldstein, S.A. Tissue engineering: functional assessment and clinical outcome. Ann N Y Acad Sci 961, 183, 2002.
6. Bucholz, R.W., Carlton, A., and Holmes, R.E. Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 18, 323, 1987.
7. Eppley, B.L., and Sadove, A.M. Management of alveolar cleft bone grafting-state of the art. Cleft Palate Craniofac J 37, 229, 2000.
8. Dimitriou, R., Jones, E., McGonagle, D., and Giannoudis, P.V. Bone regeneration: current concepts and future directions. BMC Med 9, 66, 2011.
9. Tadjoedin, E.S., de Lange, G.L., Lyaruu, D.M., Kuiper, L., and Burger, E.H. High concentrations of bioactive glass material (BioGran) vs. autogenous bone for sinus floor elevation. Clin Oral Implants Res 13, 428, 2002.
10. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
11. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
12. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G., and Mavilio, F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528, 1998.
13. Woodbury, D., Schwarz, E.J., Prockop, D.J., and Black, I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61, 364, 2000.
14. Yamada, Y., Ueda, M., Naiki, T., and Nagasaka, T. Tissueengineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Implants Res 15, 589, 2004.
15. Stephan, S.J., Tholpady, S.S., Gross, B., Petrie-Aronin, C.E., Botchway, E.A., Nair, L.S., Ogle, R.C., and Park, S.S. Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope 120, 895, 2010.
16. Chen, L., Tredget, E.E., Wu, P.Y., and Wu, Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3, e1886, 2008.
17. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543, 2004.
18. Osugi, M., Katagiri, W., Yoshimi, R., Inukai, T., Hibi, H., and Ueda, M. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A 18, 1479, 2012.
19. Shayesteh, Y.S., Khojasteh, A., Soleimani, M., Alikhasi, M., Khoshzaban, A., and Ahmadbeigi, N. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106, 203, 2008.
20. Yamada, Y., Ueda, M., Hibi, H., and Baba, S. A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology: a clinical case report. Int J Periodontics Restorative Dent 26, 363, 2006.
21. Fraser, J.K., Wulur, I., Alfonso, Z., and Hedrick, M.H. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24, 150, 2006.
22. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
23. Mizuno, H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch 76, 56, 2009.
24. Dragoo, J.L., Samimi, B., Zhu, M., Hame, S.L., Thomas, B.J., Lieberman, J.R., Hedrick, M.H., and Benhaim, P. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br Vol 85, 740, 2003.
25. Mizuno, H., Tobita, M., and Uysal, A.C. Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30, 804, 2012.
26. Parrilla, C., Saulnier, N., Bernardini, C., Patti, R., Tartaglione, T., Fetoni, A.R., Pola, E., Paludetti, G., Michetti, F., and Lattanzi, W. Undifferentiated human adipose tissuederived stromal cells induce mandibular bone healing in rats. Arch Otolaryngol Head Neck Surg 137, 463, 2011.
27. Pourebrahim, N., Hashemibeni, B., Shahnaseri, S., Torabinia, N., Mousavi, B., Adibi, S., Heidari, F., and Alavi, M.J. A comparison of tissue-engineered bone from adipose-derived stem cell with autogenous bone repair in maxillary alveolar cleft model in dogs. Int J Oral Maxillofac Surg 42, 562, 2013.
28. Moutsatsos, I.K., Turgeman, G., Zhou, S., Kurkalli, B.G., Pelled, G., Tzur, L., Kelley, P., Stumm, N., Mi, S., Muller, R., Zilberman, Y., and Gazit, D. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3, 449, 2001.
29. Turgeman, G., Pittman, D.D., Muller, R., Kurkalli, B.G., Zhou, S., Pelled, G., Peyser, A., Zilberman, Y., Moutsatsos, I.K., and Gazit, D. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3, 240, 2001.
30. Turgeman, G., Aslan, H., Gazit, Z., and Gazit, D. Cellmediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 4, 390, 2002.
31. Weibrich, G., Kleis, W.K., Hafner, G., and Hitzler, W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30, 97, 2002.
32. Landesberg, R., Roy, M., and Glickman, R.S. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 58, 297, 2000.
33. Monteiro, B.S., Del Carlo, R.J., Argolo-Neto, N.M., Nardi, N.B., Carvalho, P.H., Bonfa Lde, P., Chagastelles, P.C., Moreira, H.N., Viloria, M.I., and Santos, B.S. Association of mesenchymal stem cells with platelet rich plasma on the repair of critical calvarial defects in mice. Acta Cir Bras 27, 201, 2012.
34. Ogawa, R., Mizuno, H., Watanabe, A., Migita, M., Shimada, T., and Hyakusoku, H. Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. Biochem Biophys Res Commun 313, 871, 2004.
35. Tobita, M., Uysal, A.C., Ogawa, R., Hyakusoku, H., and Mizuno, H. Periodontal tissue regeneration with adiposederived stem cells. Tissue Eng Part A 14, 945, 2008.
36. Xiang, Z., Liao, R., Kelly, M.S., and Spector, M. Collagen-GAG scaffolds grafted onto myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. Tissue Eng 12, 2467, 2006.
37. Yoon, E., Dhar, S., Chun, D.E., Gharibjanian, N.A., and Evans, G.R. In vivo osteogenic potential of human adiposederived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 13, 619, 2007.
38. Kawamoto, T. Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch Histol Cytol 66, 123, 2003.
39. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C.J., Bovenkerk, J.E., Pell, C.L., Johnstone, B.H., Considine, R.V., and March, K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292, 2004.
40. Blaber, S.P., Webster, R.A., Hill, C.J., Breen, E.J., Kuah, D., Vesey, G., and Herbert, B.R. Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med 10, 172, 2012.
41. Nie, C., Yang, D., Xu, J., Si, Z., Jin, X., and Zhang, J. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 20, 205, 2011.
42. Nauta, A., Seidel, C., Deveza, L., Montoro, D., Grova, M., Ko, S.H., Hyun, J., Gurtner, G.C., Longaker, M.T., and Yang, F. Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing. Mol Ther 21, 445, 2013.
43. Luo, H., Zhang, Y., Zhang, Z., and Jin, Y. The protection of MSCs from apoptosis in nerve regeneration by TGFbeta1 through reducing inflammation and promoting VEGFdependent angiogenesis. Biomaterials 33, 4277, 2012.
44. Salgado, A.J., Reis, R.L., Sousa, N.J., and Gimble, J.M. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5, 103, 2010.
45. Hsiao, S.T., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G.J., Lim, S.Y., and Dilley, R.J. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev 21, 2189, 2012.
46. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., van Bruggen, N., Redmond, H.P., Carano, R.A., and Filvaroff, E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
47. Geiger, F., Bertram, H., Berger, I., Lorenz, H., Wall, O., Eckhardt, C., Simank, H.G., and Richter, W. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20, 2028, 2005.
48. Pons, J., Huang, Y., Arakawa-Hoyt, J., Washko, D., Takagawa, J., Ye, J., Grossman, W., and Su, H. VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun 376, 419, 2008.
49. Ng, F., Boucher, S., Koh, S., Sastry, K.S., Chase, L., Lakshmipathy, U., Choong, C., Yang, Z., Vemuri,M.C., Rao, M.S., and Tanavde, V. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112, 295, 2008.
50. Tozum, T.F., and Demiralp, B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc 69, 664, 2003.
51. Fiedler, J., Roderer, G., Gunther, K.P., and Brenner, R.E. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87, 305, 2002.
52. Huang, Z., Nelson, E.R., Smith, R.L., and Goodman, S.B. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng 13, 2311, 2007.
53. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
54. Foster, T.E., Puskas, B.L., Mandelbaum, B.R., Gerhardt, M.B., and Rodeo, S.A. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37, 2259, 2009.
55. Marx, R.E. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10, 225, 2001.
56. Peterson, B., Zhang, J., Iglesias, R., Kabo, M., Hedrick, M., Benhaim, P., and Lieberman, J.R. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11, 120, 2005.
57. Chou, Y.F., Zuk, P.A., Chang, T.L., Benhaim, P., and Wu, B.M. Adipose-derived stem cells and BMP2: part 1. BMP2-treated adipose-derived stem cells do not improve repair of segmental femoral defects. Connect Tissue Res 52, 109, 2011.
58. Zuk, P., Chou, Y.F., Mussano, F., Benhaim, P., and Wu, B.M. Adipose-derived stem cells and BMP2: part 2. BMP2 may not influence the osteogenic fate of human adiposederived stem cells. Connect Tissue Res 52, 119, 2011.